Dr. Reddy's Laboratories Limited Cash Flow Reinvestment Rate
Dr. Reddy's Laboratories Limited cash flow reinvestment rate. Dr. Reddy's Laboratories Limited (RDDA) has a Cash Flow Reinvestment Rate of 0.99x as of December 2025, reinvesting €10.80 Billion (capex €7.32 Billion plus investments €-3.48 Billion) from operating cash flow of €10.91 Billion. See RDDA FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Dr. Reddy's Laboratories Limited (2017–2025)
Cash flow reinvestment rate of Dr. Reddy's Laboratories Limited from 2017 to 2025. Historical reinvestment intensity for Dr. Reddy's Laboratories Limited across 9 annual periods. Explore how well can Dr. Reddy's Laboratories Limited service its debt to assess how comfortably operating cash covers total debt obligations.
Dr. Reddy's Laboratories Limited Cash Flow Reinvestment Rate by Year (2017–2025)
Dr. Reddy's Laboratories Limited cash flow reinvestment rate by year from 2017 to 2025. Year-by-year capital reinvestment analysis for Dr. Reddy's Laboratories Limited. For the full cash flow conversion analysis, see how efficiently does Dr. Reddy's Laboratories Limited generate cash.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.28x | €59.52 Billion | €46.43 Billion | €34.40 Billion | ▼ -14.0% |
| 2024 | 1.49x | €67.72 Billion | €45.43 Billion | €27.43 Billion | ▲ +45.7% |
| 2023 | 1.02x | €60.24 Billion | €58.88 Billion | €18.87 Billion | ▲ +11.2% |
| 2022 | 0.92x | €25.86 Billion | €28.11 Billion | €14.66 Billion | ▲ +137.2% |
| 2021 | 0.39x | €13.85 Billion | €35.70 Billion | €9.74 Billion | ▲ +128.8% |
| 2020 | 0.17x | €5.06 Billion | €29.84 Billion | €4.85 Billion | ▼ -47.3% |
| 2019 | 0.32x | €9.24 Billion | €28.70 Billion | €6.96 Billion | ▼ -57.6% |
| 2018 | 0.76x | €13.68 Billion | €18.03 Billion | €9.29 Billion | ▼ -52.2% |
| 2017 | 1.59x | €34.14 Billion | €21.51 Billion | €12.28 Billion | — |